bisphosphonate information from trusted sources:
Drug Safety and Availability > FDA Drug Safety Communication ...
Oct 14, 2010 ... Bisphosphonates are a class of medicines that can be effective at preventing or slowing the loss of bone mass (osteoporosis) in ...
Fosamax and bisphosphonate-associated osteonecrosis: What's the ...
Fosamax, other bisphosphonates may increase the risk of a rare but serious jaw disorder (osteonecrosis).
Bisphosphonate Associated Osteonecrosis of the Jaw: Case Summary
by MG Ferrara - Related articles
Bisphosphonate-Related Osteonecrosis of the Jaw: eMedicine ...
May 5, 2009 ... Overview: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a condition found in patients who have received intravenous and oral ...
Contents
Bisphosphonates Uses, Side Effects, Types, Effectiveness
Nov 21, 2008 ... Drug details for Bisphosphonates for osteoporosis.
Bisphosphonates
The bisphosphonates are powerful, they cause dramatic changes in the bone physiology, and they deserve respect. In women or men whose bone density T-score ...
Bisphosphonate definition - Medical Dictionary definitions of ...
Mar 14, 2011 ... Bisphosphonate: A class of drugs used to strengthen bone. Bone is in a constant state of remodeling, whereby new bone is laid down by cells ...
•UnderstandingBisphos_b3.2.indd
File Format: PDF/Adobe Acrobat - Quick View
Should I take bisphosphonate medications for osteoporosis?
Nov 21, 2008 ... This information will help you understand your choices, whether you share in the decision - making process or rely on your doctor's ...
FDA Adds Femur Fracture Warning to Bisphosphonate Labels
Bisphosphonate-Associated Osteonecrosis of the Jaw ...
Mar 20, 2010 ... The bisphosphonates are a class of drugs that inhibit the activities and functions of osteoclasts (bone resorbing cells) and perturb the ...
ADA: American Dental Association - Bisphosphonate Medication ...
Mar 9, 2009 ... If you use a bisphosphonate medication—to prevent or treat osteoporosis (a thinning of the bones) or as part of cancer treatment therapy—you ...
Bisphosphonate Use and the Risk of Subtrochanteric or Femoral ...
FDA May Revise Bisphosphonate Labels in Light of Possible Fracture ...